A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia

Journal of Developmental and Behavioral Pediatrics : JDBP
R T BrownA Madan-Swain

Abstract

This prospective study compared the intellectual and academic functioning of two groups of children treated for cancer over the 3 years after their diagnosis. One group consisted of children who received central nervous system (CNS) prophylactic chemotherapy, and the other group consisted of children with cancer who did not receive CNS chemotherapy. The results suggest that the children who received CNS chemotherapy experienced more adverse effects from their treatment in the area of academic functioning than the children who did not receive CNS chemotherapy. Although there were no differences in the academic functioning of the two groups of children immediately after their diagnosis, 3 years postdiagnosis, the CNS-treated children scored more poorly on academic tests of reading, spelling, and arithmetic than the non-CNS-treated children. The results suggest that CNS chemotherapy prophylaxis may impede academic achievement.

Citations

Nov 1, 2003·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·M Moleski
Oct 15, 2011·The New England Journal of Medicine·Lisa Diller
Feb 4, 2012·Journal of Pediatric Psychology·Marc H BornsteinMarta Pillon
Oct 4, 2005·The Cancer Journal·Smita Bhatia, Wendy Landier
Feb 24, 2000·The Journal of School Health·K M Thies
Mar 26, 2014·South Asian Journal of Cancer·Rejiv RajendranathTenali Gnana Sagar
Jan 11, 2008·AJNR. American Journal of Neuroradiology·M E CareyK L Kaemingk
Nov 5, 2013·Seminars in Oncology Nursing·Ida M Ki MooreKevin R Krull
Jul 9, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Liisa S JärveläPäivi M Lähteenmäki
Oct 17, 2008·Developmental Disabilities Research Reviews·Laura A Janzen, Brenda J Spiegler
Sep 23, 2011·Pediatric Blood & Cancer·Ida M MooreKevin R Krull
Aug 29, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nathalie C JansenWillem A Kamps
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arja H Harila-SaariRisto Sankila
Dec 17, 2015·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Courtney PeasantJames L Klosky
Apr 24, 2003·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Julia ChallinorKatherine Matthay
Mar 10, 2001·Biological Research for Nursing·C J MerkleD W Montgomery
Jul 15, 2015·Cancer Nursing·Ida M Ki MooreMarilyn J Hockenberry
Aug 21, 2013·Biological Research for Nursing·Marilyn J HockenberryIda Moore
Apr 4, 2006·Biological Research for Nursing·Ida M Ki MooreDavid W Montgomery
Jan 27, 2018·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Annette E RichardKimberley P Heinrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
V ShantaL Vasanthi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Wing LeungChing-Hon Pui
© 2021 Meta ULC. All rights reserved